NCT05612945

Brief Summary

Supervised exercise training (SET) is considered among first-line therapies for patients with symptomatic lower extremity peripheral artery disease (PAD), combined with general cardiovascular risk management, lifestyle adaptation and pharmacological treatment. Although without clear consistency, the guidelines give recommendations in terms of claudication pain severity, SET volume, duration, and frequency. However, no or little guidance is offered as far as training intensity is concerned. Most of the previous studies on SET, in the context of PAD, did not distinguish between symptom intensity and common training intensity measures such as % of maximal heart rate (%HRmax), % of HR reserve (%HRR), % of peak oxygen uptake (%VO2peak), % of VO2 reserve (%VO2R), or the rate of perceived exertion (RPE). In a recent meta-analysis, we demonstrated that both training modality and exercise intensity (based on %peak heart rate, %peak oxygen uptake, or the rate of perceived exertion) should be considered when looking for the best results in patients with symptomatic PAD. These results call for study of the individual roles of each exercise intensity and modality on walking performance and cardiorespiratory fitness in patients with symptomatic PAD. High-intensity interval training (HIIT) is composed of brief bursts of vigorous intensity interspersed with periods of rest or low-intensity exercise. HIIT may be better than moderate-intensity training (MIT) in improving cardiorespiratory fitness and functional capacity in patients with cardiovascular and metabolic diseases, but in patients with symptomatic PAD, the effects of such modalities on walking ability and cardiorespiratory fitness remain to be clearly determined. The primary objective of this study is to compare the effects of 12-week-long exercise training (short-duration high-intensity intervals vs. low-to-moderate intensity) on treadmill performance in patients with symptomatic PAD. It is hypothesized that treadmill performance would be improved to a greater extent after high-intensity exercise training

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
60

participants targeted

Target at P25-P50 for not_applicable

Timeline
17mo left

Started Mar 2023

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress71%
Mar 2023Jan 2028

First Submitted

Initial submission to the registry

October 31, 2022

Completed
10 days until next milestone

First Posted

Study publicly available on registry

November 10, 2022

Completed
4 months until next milestone

Study Start

First participant enrolled

March 1, 2023

Completed
4 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 1, 2023

Completed
4.5 years until next milestone

Study Completion

Last participant's last visit for all outcomes

January 1, 2028

Expected
Last Updated

March 15, 2024

Status Verified

March 1, 2024

Enrollment Period

4 months

First QC Date

October 31, 2022

Last Update Submit

March 11, 2024

Conditions

Keywords

ExerciseRehabilitationPhysical activity

Outcome Measures

Primary Outcomes (1)

  • Maximal walking distance

    Patients will perform an incremental treadmill test to determine the maximal walking distance (MWD). Initial walking speed will be set at 3.2 km/h, and at 0% grade. The grade will be increased by 2% each 2 min.

    This will be assessed before and after the 3-month training program. The post-program assessment will be performed between 5 to 14 days following the last training session.

Secondary Outcomes (12)

  • Functional performance - 6-minute walk test

    This will be assessed before and after the 3-month training program. The post-program assessment will be performed between 5 to 14 days following the last training session.

  • Functional performance - ascending and descending stair performance test

    This will be assessed before and after the 3-month training program. The post-program assessment will be performed between 5 to 14 days following the last training session.

  • Functional performance - short physical performance battery test

    This will be assessed before and after the 3-month training program. The post-program assessment will be performed between 5 to 14 days following the last training session.

  • Functional performance - preferred walking speed and gait analysis assessment

    This will be assessed before and after the 3-month training program. The post-program assessment will be performed between 5 to 14 days following the last training session.

  • Functional performance - unipedal stance test

    This will be assessed before and after the 3-month training program. The post-program assessment will be performed between 5 to 14 days following the last training session.

  • +7 more secondary outcomes

Study Arms (2)

High-intensity interval training group (HIIT)

EXPERIMENTAL

Exercise training sessions will consist in an alternation of brief periods (≤ 60 s) of work performed at high intensity and brief period of passive rest. Patient will be asked to complete 1 set of 10-15x60-s (or 2 sets of 5-7x60-s) walking intervals. This protocol will elicits moderate-to-severe claudication pain during exertion. The training intensity in the HIIT group will be set at ≥85% HRpeak recorded during the maximal cardiopulmonary exercise test.

Other: High-intensity interval training group (HIIT)

Low-to-moderate intensity training group (LowMod group)

EXPERIMENTAL

Exercise training sessions will consist in an alternation of periods of work performed at moderate exercise intensity and period of passive rest. The training approach of the LowMod group will be similar to the training prescription usually adopted in patients with claudication. The exercise training intensity will be set at ≤76% HRpeak recorded during the maximal cardiopulmonary exercise test.

Other: Low-to-moderate intensity training group (LowMod group)

Interventions

Exercise training sessions will consist in an alternation of brief periods (≤ 60 s) of work performed at high intensity and brief period of passive rest. Patient will be asked to complete 1 set of 10-15x60-s (or 2 sets of 5-7x60-s) walking intervals. The training intensity in the HIIT group will be set at ≥85% HRpeak recorded during the maximal cardiopulmonary exercise test. The training intervention will consist of 36 walking sessions spread over 12 weeks. Each training session will lasted 30-60 min. The training intervention will be performed on a treadmill (Cosmed T150, Itlay), which is equipped with harness and chest belt to secure the patients and prevents falling. Each session started with a 5-min walking warm-up and ended with a 5min cool-down. During all the exercise training sessions, HR of the subjects will be continuously monitored (Polar M430, Finland).

High-intensity interval training group (HIIT)

Exercise training sessions will consist in an alternation of periods of work performed at moderate exercise intensity and period of passive rest. The training approach of the LowMod group will be similar to the training prescription usually adopted in patients with claudication. The exercise training intensity will be set at ≤76% HRpeak recorded during the maximal cardiopulmonary exercise test. The training intervention will consist of 36 walking sessions spread over 12 weeks. Each training session will lasted 30-60 min. The training intervention will be performed on a treadmill (Cosmed T150, Itlay), which is equipped with harness and chest belt to secure the patients and prevents falling. Each session started with a 5-min walking warm-up and ended with a 5min cool-down. During all the exercise training sessions, HR of the subjects will be continuously monitored (Polar M430, Finland).

Low-to-moderate intensity training group (LowMod group)

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Adult patients with symptomatic PAD (Fontaine stage IIa/b);
  • ABI ≤ 0.9 or drop by 20% following exercise treadmill test 1;
  • TBI ≤ 0.6 if incompressible arteries (diabetes and renal insufficiency);
  • Signed written informed consent form.

You may not qualify if:

  • Age \< 18;
  • Unable to walk at 3.2 km/h on a treadmill (slope 0%) at least 300 m;
  • Previous participate in SET programs ≤ 1 year;
  • Prior leg/foot amputation;
  • Contraindication to exercise
  • Neurological and neuromuscular disorders and other comorbidities (orthopedic, rheumatologic) leading to gait abnormalities.
  • Known Pregnancy
  • Incapacity of discernment

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

CHUV

Lausanne, Canton of Vaud, 1011, Switzerland

RECRUITING

Related Publications (1)

  • Lanzi S, Pousaz A, Fresa M, Besson C, Desgraz B, Gremeaux-Bader V, Mazzolai L. Short-duration aerobic high-intensity intervals versus moderate exercise training intensity in patients with peripheral artery disease: study protocol for a randomised controlled trial (the Angiof-HIIT Study). BMJ Open. 2024 Apr 17;14(4):e081883. doi: 10.1136/bmjopen-2023-081883.

MeSH Terms

Conditions

Peripheral Arterial DiseaseMotor Activity

Condition Hierarchy (Ancestors)

AtherosclerosisArteriosclerosisArterial Occlusive DiseasesVascular DiseasesCardiovascular DiseasesPeripheral Vascular DiseasesBehavior

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: Monocentric randomized controlled trial (2 groups): Group 1 (n=30): high-intensity interval training group (HIIT) Group 2 (n=30): low-to-moderate intensity training group (LowMod)
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Prof, MD, PhD

Study Record Dates

First Submitted

October 31, 2022

First Posted

November 10, 2022

Study Start

March 1, 2023

Primary Completion

July 1, 2023

Study Completion (Estimated)

January 1, 2028

Last Updated

March 15, 2024

Record last verified: 2024-03

Data Sharing

IPD Sharing
Will not share

There is not a plan to make IPD available.

Locations